Here’s Why The Cigna Group (CI) Traded Lower in Q3

Market Performance - The US equity market continued to rally in Q3 2025, with the S&P 500 returning 8.1% and the Russell 1000 Value surging 5.3% [1] - The SCCM Value Equity Strategy returned 6.9% (gross) and 6.8% (net) in Q3, while year-to-date (YTD) returns were 13.0% (gross) [1] The Cigna Group (NYSE:CI) Overview - The Cigna Group, a US-based insurance company, experienced a one-month return of -10.84% and a 52-week loss of 17.60%, closing at $271.99 per share with a market capitalization of $72.656 billion on November 19, 2025 [2] - The stock selection within the Health Care sector, particularly The Cigna Group, detracted from relative performance, with a reported decline of -12.4% [3] Financial Performance and Outlook - The Cigna Group's Q3 results modestly exceeded expectations but indicated continued elevated medical cost trends and softer commercial membership [3] - The company's medical loss ratio was 83.2%, consistent with broader utilization pressures across managed care, although management reaffirmed full-year guidance [3] - Cigna's performance in specialty and care services, including biosimilars and new client growth, was highlighted as a strength [3] Hedge Fund Interest - The Cigna Group was held by 80 hedge fund portfolios at the end of Q2 2025, an increase from 74 in the previous quarter [4] - Despite the potential of The Cigna Group as an investment, certain AI stocks are considered to offer greater upside potential and less downside risk [4]